Instrument Inactif

Autres langues Cipher Pharmaceuticals Inc Nasdaq

Actions

CA17253X1050

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Cipher Pharmaceuticals : Financial Document	10/05
Cipher Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Cipher Pharmaceuticals Reports First Quarter 2024 Results	09/05
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call	06/05
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call	03/05
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference	03/04
Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023.	14/03
Cipher Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Cipher Pharmaceuticals Q4 Profit Falls 61% on Charges	14/03
Cipher Pharmaceuticals Brief: Q4 Net income and earnings per common share were US$7.7 million and $0.32, respectively	14/03
Cipher Pharmaceuticals Brief: Q4 Total revenue was US$4.9 million, consistent with Q4 2022	14/03
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results	14/03
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call	08/03
Cipher Pharmaceuticals Brief: Announcing that its common shares are now trading on the OTCQX Best Market	29/01
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading	29/01
Cipher Pharmaceuticals Announces Change of Auditor	27/11
Cipher Pharmaceuticals Announces Change of Auditor	24/11
Cipher Pharmaceuticals Announced Normal Course Issuer Bid	15/11
Cipher Pharmaceuticals Announces Normal Course Issuer Bid	15/11
Cipher Pharmaceuticals Brief: Announcing Normal Course Issuer Bid	15/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Cipher Pharmaceuticals Inc Nasdaq

Actions

CA17253X1050

Autres langues

Filtres